Home › Funds › CAPITAL FUND MANAGEMENT S.A. › EXEL

CAPITAL FUND MANAGEMENT S.A. position in EXEL

EXELIXIS INC · Health Care

CAPITAL FUND MANAGEMENT S.A. reported holding 684,488 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$40.0M, representing 0.43% of its reported portfolio and ranking #46 among its reported holdings. CAPITAL FUND MANAGEMENT S.A. has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)684.49K sh
Reported value held$39.98M
Portfolio Weight0.43%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL FUND MANAGEMENT S.A.'s EXEL position evolved

CAPITAL FUND MANAGEMENT S.A. first disclosed a stake in EXEL in Q3 2023 at 22,614 shares (US$494K). The position peaked in Q3 2026 at 684,488 shares, worth US$40.0M. Across 13 filings, CAPITAL FUND MANAGEMENT S.A. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 684,488 shares valued at US$40.0M — an increase of 157,253 shares quarter over quarter.. Notable position changes include a 342% increase in Q4 2023 (shares fell 4% over the following quarter), a 156% increase in Q1 2024 (shares fell 4% over the following quarter), a 4331% increase in Q2 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 22.61K $494.12K New
Q4 2023 99.96K $2.40M Add
Q1 2024 256.03K $6.08M Add
Q2 2024 344.92K $7.75M Add
Q3 2024 329.80K $8.56M Reduce
Q4 2024 327.58K $10.91M Reduce
Q1 2025 265.97K $9.82M Reduce
Q2 2025 283.64K $12.50M Add
Q3 2025 19.60K $809.48K Reduce
Q4 2025 11.40K $499.66K Reduce
Q1 2026 11.90K $510.39K Add
Q2 2026 527.24K $28.69M Add
Q3 2026 684.49K $39.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 41 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has CAPITAL FUND MANAGEMENT S.A. held EXEL?

CAPITAL FUND MANAGEMENT S.A. has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAPITAL FUND MANAGEMENT S.A.'s current position in EXEL?

As of Q3 2026, CAPITAL FUND MANAGEMENT S.A. holds 684.49K shares of EXEL (EXELIXIS INC), valued at $39.98M, representing 0.43% of its reported portfolio and ranking #46.

Has CAPITAL FUND MANAGEMENT S.A. been buying or selling EXEL?

In the latest 13F filing (Q3 2026), CAPITAL FUND MANAGEMENT S.A. increased its position in EXEL. The position peaked in Q3 2026 at 684.49K shares.

Which other funds hold EXEL?

Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.